BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12515380)

  • 1. Identification of cells deficient in signaling-induced alternative splicing by use of somatic cell genetics.
    Sheives P; Lynch KW
    RNA; 2002 Dec; 8(12):1473-81. PubMed ID: 12515380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of transcriptional synergy to augment sensitivity of a splicing reporter assay.
    Levinson N; Hinman R; Patil A; Stephenson CR; Werner S; Woo GH; Xiao J; Wipf P; Lynch KW
    RNA; 2006 May; 12(5):925-30. PubMed ID: 16556940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal-dependent regulation of splicing via phosphorylation of Sam68.
    Matter N; Herrlich P; König H
    Nature; 2002 Dec; 420(6916):691-5. PubMed ID: 12478298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms.
    Xu Z; Weiss A
    Nat Immunol; 2002 Aug; 3(8):764-71. PubMed ID: 12134145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient accumulation and subsequent rapid loss of messenger RNA encoding high molecular mass CD45 isoforms after T cell activation.
    Deans JP; Serra HM; Shaw J; Shen YJ; Torres RM; Pilarski LM
    J Immunol; 1992 Mar; 148(6):1898-905. PubMed ID: 1531846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of regulated pre-mRNA splicing in the immune system.
    Lynch KW
    Nat Rev Immunol; 2004 Dec; 4(12):931-40. PubMed ID: 15573128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Soluble CD80 is generated by alternative splicing, and recombinant soluble CD80 binds to CD28 and CD152 influencing T-cell activation.
    Kakoulidou M; Giscombe R; Zhao X; Lefvert AK; Wang X
    Scand J Immunol; 2007 Nov; 66(5):529-37. PubMed ID: 17953528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of alternatively spliced CD45 isoforms by channel catfish clonal T and B cells is dependent on activation state of the cell and regulated by protein synthesis and degradation.
    Kountikov E; Nayak D; Wilson M; Miller NW; Bengtén E
    Dev Comp Immunol; 2010 Oct; 34(10):1109-18. PubMed ID: 20547174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in ICOS regulates mRNA levels of ICOS and splicing isoforms of CTLA4.
    Kaartinen T; Lappalainen J; Haimila K; Autero M; Partanen J
    Mol Immunol; 2007 Mar; 44(7):1644-51. PubMed ID: 16996590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signals, pathways and splicing regulation.
    Blaustein M; Pelisch F; Srebrow A
    Int J Biochem Cell Biol; 2007; 39(11):2031-48. PubMed ID: 17507279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperoxia induces Egr-1 expression through activation of extracellular signal-regulated kinase 1/2 pathway.
    Jones N; Agani FH
    J Cell Physiol; 2003 Aug; 196(2):326-33. PubMed ID: 12811826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auxiliary splice factor U2AF26 and transcription factor Gfi1 cooperate directly in regulating CD45 alternative splicing.
    Heyd F; ten Dam G; Möröy T
    Nat Immunol; 2006 Aug; 7(8):859-67. PubMed ID: 16819553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing.
    Hernández-Caselles T; Martínez-Esparza M; Pérez-Oliva AB; Quintanilla-Cecconi AM; García-Alonso A; Alvarez-López DM; García-Peñarrubia P
    J Leukoc Biol; 2006 Jan; 79(1):46-58. PubMed ID: 16380601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a cellular model to study alternative splicing of type II collagen gene.
    Hatano H; Sarkar G; Bolander ME
    J Orthop Res; 2002 May; 20(3):516-9. PubMed ID: 12038625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD45 isoforms in T cell signalling and development.
    McNeill L; Cassady RL; Sarkardei S; Cooper JC; Morgan G; Alexander DR
    Immunol Lett; 2004 Mar; 92(1-2):125-34. PubMed ID: 15081536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells.
    Mukherjee P; Tinder TL; Basu GD; Gendler SJ
    J Leukoc Biol; 2005 Jan; 77(1):90-9. PubMed ID: 15513966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells.
    Conde P; Acosta-Saavedra LC; Goytia-Acevedo RC; Calderon-Aranda ES
    Arch Toxicol; 2007 Apr; 81(4):251-9. PubMed ID: 17009048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reishi immuno-modulation protein induces interleukin-2 expression via protein kinase-dependent signaling pathways within human T cells.
    Hsu HY; Hua KF; Wu WC; Hsu J; Weng ST; Lin TL; Liu CY; Hseu RS; Huang CT
    J Cell Physiol; 2008 Apr; 215(1):15-26. PubMed ID: 18189229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
    Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.